The Leukemia & Lymphoma Society, MN/ND/SD Chapter

KIDS ARE DIFFERENT

and should be treated differently for their blood cancers.

Introducing The Dare to Dream Project - the bigger, bolder, next phase of LLS Children's Initiative. The Leukemia & Lymphoma Society (LLS) recognizes kids are different and their blood cancers need to be treated differently, so we are daring to change the paradigm of treatment and care of pediatric blood cancers. Our dream is to help as many children as possible get treatment for their cancer. We've already facilitated progress by funding a first-ever pediatric AML Data Commons, a platform that ensures consistency in global data reporting, and by launching the first-ever acute leukemia LLS PedAL Master Clinical Trial, matching patients to treatment based on their cancer's unique tumor biology.

In Minnesota, we're proud to have the LLS master PedAL clinical trial (pediatric acute leukemia) running at University of Minnesota Masonic Children's Hospital, Children's of Minnesota, and Mayo Clinic. Not only is this initiative global in scope, but also extremely local in order to bring the treatment to the patient rather than make the patient travel to the treatment. 

We know there are so many worthy causes to consider supporting today, so we are grateful for your consideration of the LLS Dare to Dream Project. Our kids deserve better! For more information about this exciting initiative, visit here: https://www.lls.org/dare-to-dream